Kensington Investment Counsel, LLC Novartis Ag Transaction History
Kensington Investment Counsel, LLC
- $239 Million
- Q4 2024
A detailed history of Kensington Investment Counsel, LLC transactions in Novartis Ag stock. As of the latest transaction made, Kensington Investment Counsel, LLC holds 9,460 shares of NVS stock, worth $1.09 Million. This represents 0.39% of its overall portfolio holdings.
Number of Shares
9,460
Previous 9,460
-0.0%
Holding current value
$1.09 Million
Previous $1.09 Million
15.44%
% of portfolio
0.39%
Previous 0.46%
Shares
16 transactions
Others Institutions Holding NVS
# of Institutions
1,479Shares Held
134MCall Options Held
1.31MPut Options Held
1.56M-
Dodge & Cox San Francisco, CA12.2MShares$1.41 Billion0.74% of portfolio
-
Primecap Management CO Pasadena, CA11MShares$1.27 Billion0.85% of portfolio
-
Dimensional Fund Advisors LP Austin, TX8.18MShares$945 Million0.2% of portfolio
-
Morgan Stanley New York, NY6.87MShares$793 Million0.05% of portfolio
-
Loomis Sayles & CO L P5.58MShares$644 Million0.68% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $248B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...